Literature DB >> 11947892

Vascular effects of dietary L-arginine supplementation.

Robert B Preli1, Karen Potvin Klein, David M Herrington.   

Abstract

The vascular endothelium is acknowledged to play an important role in vascular physiology. Attention has focused on endothelial production of nitric oxide as a key element in many of the processes associated with the development of atherosclerosis. L-arginine is the substrate for the enzyme nitric oxide synthase (NOS), which is responsible for the endothelial production of nitric oxide. Therefore, many investigators have been interested in whether dietary L-arginine supplementation can augment nitric oxide production and thereby improve vascular health. The effects of oral L-arginine on vascular health and disease have been examined both in human beings and in various animal models. In this review, we summarize the results of studies of oral L-arginine supplementation on atherosclerotic lesion formation, as well as markers of endothelial function (e.g. macrophage function, platelet aggregation and adhesion, and in vitro vascular ring studies). Although results of oral L-arginine supplementation in hypercholesterolemic animals have generally shown beneficial effects, the data in humans are varied, possibly because of small sample sizes and brief periods of study. Long-term randomized clinical trials are needed to more definitively address whether oral L-arginine supplementation could be advantageous for vascular health.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11947892     DOI: 10.1016/s0021-9150(01)00717-1

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  30 in total

Review 1.  The postprandial effects of dietary antioxidants in humans.

Authors:  Colin D Kay; Bruce J Holub
Journal:  Curr Atheroscler Rep       Date:  2003-11       Impact factor: 5.113

Review 2.  Age-related endothelial dysfunction : potential implications for pharmacotherapy.

Authors:  Rachel L Matz; Ramaroson Andriantsitohaina
Journal:  Drugs Aging       Date:  2003       Impact factor: 3.923

Review 3.  Mechanisms, significance and treatment of vascular dysfunction in type 2 diabetes mellitus: focus on lipid-regulating therapy.

Authors:  Richard J Woodman; Gerard T Chew; Gerald F Watts
Journal:  Drugs       Date:  2005       Impact factor: 9.546

Review 4.  L-arginine as a nutritional prophylaxis against vascular endothelial dysfunction with aging.

Authors:  Kevin S Heffernan; Christopher A Fahs; Sushant M Ranadive; Eshan A Patvardhan
Journal:  J Cardiovasc Pharmacol Ther       Date:  2010-01-06       Impact factor: 2.457

5.  L-Arginine supplementation does not enhance blood flow and muscle performance in healthy and physically active older women.

Authors:  Andreo Fernando Aguiar; Mario Carlos Welin Balvedi; Cosme Franklim Buzzachera; Leandro Ricardo Altimari; Marcell Alysson Batisti Lozovoy; Marcelo Bigliassi; Renata Selvatici Borges Januário; Rafael Mendes Pereira; Vanda Cristina Sanches; Douglas Kratki da Silva; Guilherme Atsushi Muraoka
Journal:  Eur J Nutr       Date:  2015-08-18       Impact factor: 5.614

6.  Arginine and antioxidant supplement on performance in elderly male cyclists: a randomized controlled trial.

Authors:  Steve Chen; Woosong Kim; Susanne M Henning; Catherine L Carpenter; Zhaoping Li
Journal:  J Int Soc Sports Nutr       Date:  2010-03-23       Impact factor: 5.150

7.  Arginase activities and global arginine bioavailability in wild-type and ApoE-deficient mice: responses to high fat and high cholesterol diets.

Authors:  Aaron Erdely; Diane Kepka-Lenhart; Rebecca Salmen-Muniz; Rebecca Chapman; Tracy Hulderman; Michael Kashon; Petia P Simeonova; Sidney M Morris
Journal:  PLoS One       Date:  2010-12-06       Impact factor: 3.240

8.  Daily egg consumption in hyperlipidemic adults--effects on endothelial function and cardiovascular risk.

Authors:  Valentine Njike; Zubaida Faridi; Suparna Dutta; Anjelica L Gonzalez-Simon; David L Katz
Journal:  Nutr J       Date:  2010-07-02       Impact factor: 3.271

9.  L-arginine supplementation reduces cardiac noradrenergic neurotransmission in spontaneously hypertensive rats.

Authors:  Chee-Wan Lee; Dan Li; Keith M Channon; David J Paterson
Journal:  J Mol Cell Cardiol       Date:  2009-04-09       Impact factor: 5.000

10.  DASH lowers blood pressure in obese hypertensives beyond potassium, magnesium and fibre.

Authors:  Y Al-Solaiman; A Jesri; W K Mountford; D T Lackland; Y Zhao; B M Egan
Journal:  J Hum Hypertens       Date:  2009-07-23       Impact factor: 3.012

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.